Amgen Inc
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3023% above fair value
$435.64−3.18 (-0.72%)
Close on Nov 20, 2026Market cap $235.52BP/E 25.3Yield 2.22%
Amgen CEO Annual Total Compensation by Year
CEO Annual Total Compensation ($) ($)
Amgen CEO Annual Total Compensation: $24,693,120 in FY2025, up 1.1% from a year earlier.
Latest, FY2025
24,693,120
Period ended Dec 31, 2025
Change on a year earlier
+1.1%
24,428,495 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Where the FY2025 figure comes from
“We then determined the annual total compensation of our median employee for 2025 which was $154,123. As disclosed in the “Summary Compensation Table” appearing on page 83, our CEO’s annual total compensation for 2025 was $24,693,120. Based on the foregoing, the ratio of the annual total compensation of our CEO to that of the median staff member was 160 to 1.”
Source: Proxy Statement (DEF 14A) (d13946ddef14a.htm, filed 2026-04-07) ↗
Reported in DEF 14A Proxy Statement — CEO Pay Ratio Disclosure.
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CEO Annual Total Compensation ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24,693,120 | +1.1% | Proxy Statement (DEF 14A) (d13946ddef14a.htm, filed 2026-04-07) ↗ |
| FY2024 | Dec 31, 2024 | 24,428,495 | +7.9% | Proxy Statement (DEF 14A) (amgn-20250408.htm, filed 2025-04-09) ↗ |
| FY2023 | Dec 31, 2023 | 22,643,650 | +5.8% | Proxy Statement (DEF 14A) (d445034ddef14a.htm, filed 2024-04-17) ↗ |
| FY2022 | Dec 31, 2022 | 21,399,733 | -1.5% | Proxy Statement (DEF 14A) (d371686ddef14a.htm, filed 2023-04-06) ↗ |
| FY2021 | Dec 31, 2021 | 21,721,154 | +7.9% | Proxy Statement (DEF 14A) (d234450ddef14a.htm, filed 2022-04-05) ↗ |
| FY2020 | Dec 31, 2020 | 20,131,408 | +2.6% | Proxy Statement (DEF 14A) (d107745ddef14a.htm, filed 2021-04-06) ↗ |
| FY2019 | Dec 31, 2019 | 19,612,793 | – | Proxy Statement (DEF 14A) (d846287ddef14a.htm, filed 2020-04-07) ↗ |
Cite this data
StockData. (2026). Amgen CEO Annual Total Compensation ($), annual FY2019–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/proxy-ceo-comp
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.
See a number that looks wrong?